Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Not applicable Interventional

From Burnout to Balance: Implementing a Theory-Driven Resiliency Program in Occupational Therapy Doctoral Education

ClinicalTrials.gov ID: NCT07848230

Public ClinicalTrials.gov record NCT07848230. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 2, 2026, 9:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to learn about burnout among first-year Occupational Therapy Doctoral (OTD) students and how it may affect their mental health, daily activities, and overall well-being. Students will be asked questions about their stress levels, daily habits, and experiences in school. The study will also evaluate a resilience program that is built into a hybrid OTD curriculum to see whether it helps students manage stress, improve their well-being, perform well academically, and support their long-term success. Researchers will look for patterns in the responses to better understand student experiences. The findings may help occupational therapy programs and other healthcare schools provide better support for students.

Study identification

NCT ID
NCT07848230
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Not applicable
Enrollment
30 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 1, 2026 (Actual)
Primary completion
Apr 30, 2027 (Estimated)
Completion
Jun 30, 2027 (Estimated)
Last update posted
Sep 29, 2026

2026 – 2027

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Nova Southeastern University Clearwater Florida 33759-4514 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07848230, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 29, 2026 · Synced Oct 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07848230 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →